Financial results - BIOMED PLUS SRL

Financial Summary - Biomed Plus Srl
Unique identification code: 14885840
Registration number: J16/817/2002
Nace: 8622
Sales - Ron
21.766
Net Profit - Ron
4.294
Employees
1
Open Account
Company Biomed Plus Srl with Fiscal Code 14885840 recorded a turnover of 2024 of 21.766, with a net profit of 4.294 and having an average number of employees of 1. The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron

Sales, Profit, Employees, Total Income, Financial Results - Biomed Plus Srl

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Sales - EUR 1.569 3.124 3.713 6.808 9.715 8.009 3.705 6.682 13.120 21.766
Total Income - EUR 1.653 3.126 3.713 6.809 9.722 8.009 3.705 6.682 13.120 22.458
Total Expenses - EUR 7.533 4.696 4.175 7.161 9.085 5.806 5.133 8.142 15.157 17.500
Gross Profit/Loss - EUR -5.880 -1.570 -463 -352 637 2.203 -1.428 -1.460 -2.037 4.957
Net Profit/Loss - EUR -5.929 -1.663 -574 -549 345 1.986 -1.539 -1.558 -2.168 4.294
Employees 2 2 2 2 1 1 1 1 1 1
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded. In the last year of activity, the sales increased by 66.8%, from 13.120 euro in the year 2023, to 21.766 euro in 2024. The Net Profit increased by 4.294 euro, from 0 euro in 2023, to 4.294 in the last year.
Sales - Ron
Net Profit - Ron
Employees

Check the financial reports for the company - Biomed Plus Srl

Rating financiar

Financial Rating -
BIOMED PLUS SRL

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Financial Rating
Limite de plata

Payment Limits -
Biomed Plus Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Biomed Plus Srl

It determines the risk of insolvency based on the submitted accounting balance.

Insolvency Probability
Rapoarte financiare

Financial Reports -
Biomed Plus Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Biomed Plus Srl - CUI 14885840

2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Fixed Assets 0 0 0 0 0 0 0 0 0 0
Current Assets 2.694 1.275 361 551 385 2.183 590 582 986 2.215
Inventories 0 0 0 0 0 0 0 0 0 0
Receivables 239 237 232 229 225 221 216 216 216 0
Cash 2.455 1.039 128 322 160 1.962 375 366 770 2.215
Shareholders Funds 1.533 -147 -718 -1.255 -885 1.118 -446 -2.005 -4.167 150
Social Capital 67 67 66 64 63 62 61 61 61 60
Debts 1.162 1.422 1.079 1.806 1.270 1.065 1.036 2.587 5.153 2.065
Income in Advance 0 0 0 0 0 0 0 0 0 0
Exchange rate - RON 4.9743 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445
Main CAEN "8622 - 8622"
CAEN Financial Year 8622
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 2.215 euro in 2024 which includes Inventories of 0 euro, Receivables of 0 euro and cash availability of 2.215 euro.
The company's Equity was valued at 150 euro, while total Liabilities amounted to 2.065 euro. Equity increased by 4.294 euro, from -4.167 euro in 2023, to 150 in 2024.

Risk Reports Prices

Reviews - Biomed Plus Srl

Comments - Biomed Plus Srl

Similar services useful for checking companies and business development.

SellNet

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Databases

Export in excel files the data of the companies selected according to the desired criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.